[go: up one dir, main page]

ZA200507995B - Process for the preparation of anticonvulsant derivatives of topiramate - Google Patents

Process for the preparation of anticonvulsant derivatives of topiramate Download PDF

Info

Publication number
ZA200507995B
ZA200507995B ZA200507995A ZA200507995A ZA200507995B ZA 200507995 B ZA200507995 B ZA 200507995B ZA 200507995 A ZA200507995 A ZA 200507995A ZA 200507995 A ZA200507995 A ZA 200507995A ZA 200507995 B ZA200507995 B ZA 200507995B
Authority
ZA
South Africa
Prior art keywords
compound
formula
aqueous organic
base
sulfuryl diamide
Prior art date
Application number
ZA200507995A
Other languages
English (en)
Inventor
Berkner Joachim Ernst
Mills John
Duncan Scott
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of ZA200507995B publication Critical patent/ZA200507995B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
ZA200507995A 2003-03-04 2005-10-03 Process for the preparation of anticonvulsant derivatives of topiramate ZA200507995B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45186303P 2003-03-04 2003-03-04

Publications (1)

Publication Number Publication Date
ZA200507995B true ZA200507995B (en) 2007-01-31

Family

ID=32962650

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200507995A ZA200507995B (en) 2003-03-04 2005-10-03 Process for the preparation of anticonvulsant derivatives of topiramate

Country Status (27)

Country Link
US (1) US7157589B2 (pt)
EP (1) EP1599490B8 (pt)
JP (1) JP4725976B2 (pt)
KR (1) KR20050119111A (pt)
CN (1) CN100376591C (pt)
AR (1) AR043466A1 (pt)
AT (1) ATE421521T1 (pt)
AU (1) AU2004217974A1 (pt)
BR (1) BRPI0407967A (pt)
CA (1) CA2517964A1 (pt)
CL (1) CL2004000438A1 (pt)
DE (1) DE602004019191D1 (pt)
DK (1) DK1599490T3 (pt)
ES (1) ES2254047T3 (pt)
HK (1) HK1088336A1 (pt)
HR (1) HRP20050756A2 (pt)
MX (1) MXPA05009384A (pt)
MY (1) MY139235A (pt)
NO (1) NO20054538L (pt)
NZ (1) NZ541811A (pt)
PT (1) PT1599490E (pt)
RU (1) RU2333216C2 (pt)
SI (1) SI1599490T1 (pt)
TW (1) TW200504089A (pt)
UA (1) UA81657C2 (pt)
WO (1) WO2004078769A1 (pt)
ZA (1) ZA200507995B (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US7638291B2 (en) 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2008010231A2 (en) * 2006-05-26 2008-01-24 Alembic Limited A process for the purification of topiramate
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
WO2014037832A2 (en) * 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of epilepsy and neurological diseases
US9399634B2 (en) 2012-05-07 2016-07-26 Cellix Bio Private Limited Compositions and methods for the treatment of depression
AU2013257742A1 (en) 2012-05-07 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
US9738631B2 (en) 2012-05-07 2017-08-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
US9266823B2 (en) 2012-05-08 2016-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
WO2013167992A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of inflammatory disorders
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
US9394288B2 (en) 2012-05-10 2016-07-19 Cellix Bio Private Limited Compositions and methods for the treatment of asthma and allergy
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013168033A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
WO2013168000A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of severe pain
WO2013168004A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of fibromyalgia pain
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2013168012A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
US9403857B2 (en) 2012-05-10 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9315478B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
NZ701832A (en) 2012-05-23 2016-08-26 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
CA2873104A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of mucositis
US9227974B2 (en) 2012-05-23 2016-01-05 Cellex Bio Private Limited Compositions and methods for the treatment of respiratory disorders
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
EP2852569B1 (en) 2012-05-23 2020-10-14 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
WO2013175344A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en) 2012-08-03 2014-02-06 Mahesh Kandula Compositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
SG11201407325YA (en) 2012-09-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of inflammation and lipid disorders
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en) 2013-06-04 2015-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
US10227301B2 (en) 2015-01-06 2019-03-12 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation and pain
NZ736131A (en) 2014-09-26 2019-04-26 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
CN107207403A (zh) 2014-09-29 2017-09-26 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的组合物和方法
CN107108535B (zh) 2014-10-27 2020-04-28 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的富马酸单甲酯与哌嗪或乙二胺的三组分盐
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
CN106632530A (zh) * 2016-12-08 2017-05-10 陕西大生制药科技有限公司 高纯度托吡酯的制备方法
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol

Also Published As

Publication number Publication date
UA81657C2 (ru) 2008-01-25
WO2004078769A1 (en) 2004-09-16
EP1599490B1 (en) 2009-01-21
ATE421521T1 (de) 2009-02-15
AU2004217974A1 (en) 2004-09-16
EP1599490B8 (en) 2009-04-08
DE602004019191D1 (de) 2009-03-12
SI1599490T1 (sl) 2009-06-30
CN100376591C (zh) 2008-03-26
ES2254047T3 (es) 2009-05-14
AR043466A1 (es) 2005-07-27
KR20050119111A (ko) 2005-12-20
BRPI0407967A (pt) 2006-03-07
HK1088336A1 (en) 2006-11-03
CL2004000438A1 (es) 2005-01-21
US7157589B2 (en) 2007-01-02
RU2005127626A (ru) 2006-01-27
ES2254047T1 (es) 2006-06-16
RU2333216C2 (ru) 2008-09-10
HRP20050756A2 (en) 2006-07-31
JP4725976B2 (ja) 2011-07-13
CA2517964A1 (en) 2004-09-16
NZ541811A (en) 2008-07-31
CN1756760A (zh) 2006-04-05
MXPA05009384A (es) 2006-02-28
NO20054538L (no) 2005-10-03
EP1599490A1 (en) 2005-11-30
JP2006519860A (ja) 2006-08-31
DK1599490T3 (da) 2009-04-27
US20040215004A1 (en) 2004-10-28
PT1599490E (pt) 2009-04-03
TW200504089A (en) 2005-02-01
MY139235A (en) 2009-09-30

Similar Documents

Publication Publication Date Title
ZA200507995B (en) Process for the preparation of anticonvulsant derivatives of topiramate
SE462850B (sv) 1-(hydroximetyl)-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- eller -tiazino/4,3-a/isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem
AU2021314375A1 (en) Method for large-scale synthesis of tetrodotoxin
KR102689384B1 (ko) 엔잘루타미드를 제조하는 방법
Rajappa et al. Quinone-imides: regiospecificity of nucleophilic attack on n-alkanesulphonyl-n'-alkanoyl 14-benzoquinone-imines.
AU2007287386B2 (en) Process for the manufacture of HI-6 dimethanesulfonate
KR20240056726A (ko) 니로가세스타트의 합성
Grehn et al. Synthesis and use of benzyl tert-butyl iminodicarbonate, a versatile reagent for the preparation of amines
WO2004108732A1 (en) PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE
EP1558624B1 (en) Continuous process for the preparation of fructopyranose sulfamate derivatives
ZA200504408B (en) Continuous process for the preparation of fructopyranose sulfamate derivatives
PT1802635E (pt) Compostos tricíclicos contendo heteroátomos
Tafesse et al. An efficient parallel synthesis of capsazepine and capsazepine analogs
EP1051402A1 (de) Verfahren zur herstellung von s-alkyl(aryl)-substituierten imidazol-derivaten
DE3534774A1 (de) Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
JPH07291942A (ja) カルボアサイクリックヌクレオシド誘導体およびその合成用中間体
PL97877B2 (pt)
WO2002072595A2 (de) Verfahren zur herstellung von pentopyranosyl-nucleosiden
WO1993025518A1 (en) NOVEL PROCESS FOR THE PREPARATION OF α-AMINOACYLANILIDES
CZ319599A3 (cs) Způsob přípravy derivátů esterů kyseliny máselné